The discovery and development of the triptans, a major therapeutic breakthrough

被引:48
作者
Humphrey, Patrick P. A. [1 ]
机构
[1] Theravance Inc, San Francisco, CA USA
来源
HEADACHE | 2008年 / 48卷 / 05期
关键词
D O I
10.1111/j.1526-4610.2008.01097.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The drug discovery programs that led to the development of the triptans were determined by the membership of the American Headache Society to be the most important breakthrough in headache medicine in the last 50 years. Dr. Humphrey, who spearheaded the drug discovery, recounts the pioneering work that took place and examines its therapeutic impact.
引用
收藏
页码:685 / 687
页数:3
相关论文
共 9 条
  • [1] PLASMA SEROTONIN IN MIGRAINE AND STRESS
    ANTHONY, M
    HINTERBERGER, H
    LANCE, JW
    [J]. ARCHIVES OF NEUROLOGY, 1967, 16 (05) : 544 - +
  • [2] NEUROPEPTIDES IN MIGRAINE AND CLUSTER HEADACHE
    EDVINSSON, L
    GOADSBY, PJ
    [J]. CEPHALALGIA, 1994, 14 (05) : 320 - 327
  • [3] Emerging therapies for migraine
    Goadsby, Peter J.
    [J]. NATURE CLINICAL PRACTICE NEUROLOGY, 2007, 3 (11): : 610 - 619
  • [4] The discovery of a new drug class for the acute treatment of migraine
    Humphrey, Patrick P. A.
    [J]. HEADACHE, 2007, 47 : S10 - S19
  • [5] GR43175, A SELECTIVE AGONIST FOR THE 5-HT1-LIKE RECEPTOR IN DOG ISOLATED SAPHENOUS-VEIN
    HUMPHREY, PPA
    FENIUK, W
    PERREN, MJ
    CONNOR, HE
    OXFORD, AW
    COATES, IH
    BUTINA, D
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1988, 94 (04) : 1123 - 1132
  • [6] 5-HYDROXYTRYPTAMINE AND THE PATHOPHYSIOLOGY OF MIGRAINE
    HUMPHREY, PPA
    [J]. JOURNAL OF NEUROLOGY, 1991, 238 : S38 - S44
  • [7] How it started
    Humphrey, PPA
    [J]. CEPHALALGIA, 2001, 21 : 2 - 5
  • [8] HUMPHREY PPA, 2001, TRIPTANS NOVEL DRUGS
  • [9] EFFECT OF SEROTONIN IN MIGRAINE PATIENTS
    KIMBALL, RW
    FRIEDMAN, AP
    VALLEJO, E
    [J]. NEUROLOGY, 1960, 10 (02) : 107 - 111